Bookmark

Add to MyYahoo RSS

Eli Lilly News

News on Eli Lilly (Ticker: LLY) continually updated from thousands of sources around the net.

12 hrs ago | Freshnews

New Data Shows Combination Therapy is More Effective than Monotherapy ...

Eli Lilly and Company today announced results from its non-clinical study in genetically engineered mice examining combination therapy with the murine version of the beta-amyloid antibody N3pG and beta-secretase inhibitor BACE .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Alzheimer's, Health, World News, Denmark,

Thu Jul 10, 2014

Freshnews

Lilly for Better Health(TM) expands website's...

Eli Lilly and Company has rebooted the Lilly for Better Health program, with several innovative enhancements to lillyforbetterhealth.com that help enrich the user experience with Lilly's non-product-branded health education.

Comment?

Related Topix: Biotech, Healthcare Industry, Life, Food, Nutrition, UC Berkeley, Berkeley, CA

Wed Jul 09, 2014

Theflyonthewall.com

Casey's General Stores sees FY15 dividend 80c per share

On The Fly: Analyst Upgrade Summary Today's noteworthy upgrades include: AbbVie upgraded to Overweight from Equal Weight at Barclays... Alcatel-Lucent upgraded to Overweight from Neutral at JPMorgan... BG Group upgraded to Buy from Hold at Canaccord... Baker Hughes upgraded to Neutral from Sell at Guggenheim... Bank of America upgraded to Buy from ... (more)

Comment?

Related Topix: Retail, Caseys General Stores, Telecom, Alcatel, Alcatel-Lucent, Baker Hughes, Oil & Gas, Banking, Bank of America, Financial Services, Biotech, Medicine, Healthcare Industry

Freshnews

Lilly Confirms Date and Conference Call for Second-Quarter 2014 Financial Results Announcement

Eli Lilly and Company will announce its financial results for the second quarter of 2014 on Thursday, July 24, 2014.

Comment?

Related Topix: Eli Lilly, Biotech, Medicine, Healthcare Industry

Tue Jul 08, 2014

Reuters

Sanofi sues Eli Lilly over insulin rival to Lantus

Sanofi SA, whose top-selling Lantus helps diabetics control blood sugar levels, has filed a lawsuit accusing Eli Lilly and Co of infringing seven patents related to insulin and devices used to deliver it.

Comment?

Related Topix: Medicine, Lantus, Insulin Glargine (generic), Biotech, Insulin (generic), Humulin, Novolin, Healthcare Industry, Genzyme General, Origin Healthcare Solutions, Acambis

TheStreet.com

Why Eli Lilly (LLY) Stock Is Down This Afternoon

Through its complaint made public on Tuesday in the U.S. District Court in Wilmington, DE, Sanofi is seeking to halt Lilly's proposed commercial marketing in the U.S. of a rival treatment, known as Abasria, saying the sale would violate its rights, Reuters noted.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Wilmington, DE, Financial Markets

Applied Clinical Trials

Lilly to Showcase Data from its Alzheimer's Disease Portfolio at the...

Lilly to Showcase Data from its Alzheimer's Disease Portfolio at the Alzheimer's Association International Conference 2014 Highlights include additional analyses from Phase 3 and ongoing open-label studies, discovery research on the potential use of combination therapy and data on the impact of beta-amyloid imaging on diagnosis and management Lilly ... (more)

Comment?

Related Topix: Alzheimer's, Health, Biotech, Medicine, Healthcare Industry

Mon Jul 07, 2014

JD Supra

Court Report - July 2014 #2

Eli Lilly and Company et al. v. Panacea Biotec, Ltd. 1:14-cv-01064; filed June 26, 2014 in the Southern District of Indiana Infringement of certain of U.S. Patent Nos.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

BioSpace

Yabao Pharmaceuticals Enters Innovative Partnership With Eli Lilly...

Lilly's GKA has completed Phase 1 studies in the US in addition to extensive pre-clinical development.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Insulin (generic), Humulin, Novolin, Diabetes, Health

Sun Jul 06, 2014

Chemical and Engineering News

Firms Target Insulin Market

A review committee of the European Medicines Agency has recommended approval of an investigational insulin compound developed jointly by Eli Lilly & Co.

Comment?

Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Biotech, Healthcare Industry, Lantus, Insulin Glargine (generic), Diabetes, Health

The Motley Fool

Is Europe Igniting Eli Lilly's Comeback?

The CHMP, Europe's equivalent of an FDA advisory committee that almost always gets its way, recently issues a slew of recommendations for the EU's health agency.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Diabetes, Health, Lantus, Insulin Glargine (generic), Insulin (generic), Humulin, Novolin

Thu Jul 03, 2014

Minyanville

Stock Upgrades: Cree Can See by the Dawn's Early Light-Emitting Diode

You will receive a download link right in your email inbox for each of the free reports that you choose.

Comment?

Related Topix: Cree, Semiconductors, Electronics, Beverages, Constellation Brands, Biotech, Medicine, Healthcare Industry, Eli Lilly

Wed Jul 02, 2014

Patently Obvious

Federal Circuit: To Satisfy the Written Description Requirement, a...

This decision is important in the way that it confirms a strong Post- Ariad Written Description requirement - especially with regard to genus-species claim situations.

Comment?

Related Topix: Medicine, Inventions, Science / Technology, Biotech, Healthcare Industry

Barron's

No Perfect Prescription: Barclays Cuts Bristol-Myers, Upgrades AbbVie

Pharmaceutical stocks like Eli Lilly , Merck and AbbVie had a great first half of 2014.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Financial Markets, Merck

Minyanville

Stock Upgrades: Eli Lilly Boosted by Love and Other Drugs

You will receive a download link right in your email inbox for each of the free reports that you choose.

Comment?

Related Topix: Imclone Systems, Biotech, Medicine, Healthcare Industry, Eli Lilly, Financial Markets, Netflix, Startups, Intuitive Surgical

Benzinga

's Top Upgrades

Analysts at Deutsche Bank upgraded Bank of America from "hold" to "buy." The target price for Bank of America has been raised from $16.50 to $18.

Comment?

Related Topix: Banking, Bank of America, Financial Services, Baker Hughes, Oil & Gas, Biotech, Medicine, Healthcare Industry

Mon Jun 30, 2014

The Motley Fool

Danger Ahead for Investors in this $8 Billion Blockbuster

Lantus is one of the world's best selling drugs, clocking $8 billion per year in revenue, and a cornerstone of Sanofi 's business.

Comment?

Related Topix: Medicine, Lantus, Insulin Glargine (generic), Biotech, Healthcare Industry, Diabetes, Health, Medtronic, Medical Equipment

Sun Jun 29, 2014

The Motley Fool

Should Dividend Investors Eject Eli Lilly and Co?

Watch and find out the current strengths and weaknesses of Eli Lilly and if it should be ejected by investors.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri Jun 27, 2014

Business Journal

Decision coming on biotech KineMed's stalled IPO

KineMed Inc. could opt to withdraw its planned $41 million IPO after investors dissed the Emeryville biotech company's desired price.

Comment?

Related Topix: Startups, KineMed, Biotech, Medicine, Healthcare Industry, San Mateo County, CA, San Francisco County, CA, San Francisco, CA, South San Francisco, CA

The Washington Post

Lilly Wins EU Backing for Generic of Sanofi's Lantus Insulin

Eli Lilly & Co. won European backing for a generic version of Sanofi's Lantus insulin, paving the way for the first copycat of the French drugmaker's top-selling medicine.

Comment?

Related Topix: Medicine, Lantus, Insulin Glargine (generic), Insulin (generic), Humulin, Novolin, Biotech, Healthcare Industry, Diabetes, Health, Business News

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••